PD-L1 blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Zhu, Weimin ^a   Bao, Rui ^a   Fan, Xiaohua ^a   Tao, Tianzhu ^a   Zhu, Jiali ^a   Wang, Jiafeng ^a   Li, Jinbao ^a   Bo, Lulong ^a   Deng, Xiaoming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; PROGRAMMED DEATH 1 LIGAND 1; TUMOR NECROSIS FACTOR ALPHA; ACUTE PHASE PROTEIN; CD274 PROTEIN, MOUSE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME RELEASE; EXPERIMENTAL LIGATION; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LIVER CELL; LIVER HYPERTROPHY; LIVER INJURY; LIVER VENOOCCLUSIVE DISEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSCRIPTION; SEPSIS; SINGLE DRUG DOSE; THERAPY EFFECT; UPREGULATION; ANIMAL; C57BL MOUSE; CECUM; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; IMMUNOLOGICAL TOLERANCE; INJURY; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

MUS;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIGENS, CD274; CECUM; GENE EXPRESSION REGULATION; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED C57BL; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84890059609     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/361501     Document Type: Article

References (23)

1. Skrupky L. P., Kerby P. W., Hotchkiss R. S., Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology 2011 115 6 1349 1362 2-s2.0-81855185336 10.1097/ALN.0b013e31823422e8
2. Nesseler N., Launey Y., Aninat C., Morel F., Malledant Y., Seguin P., Clinical Review. Crit Care 2012 16 5 235
3. Spapen H., Liver perfusion in sepsis, septic shock, and multiorgan failure. Anatomical Record 2008 291 6 714 720 2-s2.0-45849115860 10.1002/ar.20646
4. Famularo G., De Simone C., Nicotra G. C., Jaundice and the sepsis syndrome: a neglected link. European Journal of Internal Medicine 2003 14 4 269 271 2-s2.0-0042206377 10.1016/S0953-6205(03)00072-4 (Pubitemid 36952709)
5. Boomer J. S., To K., Chang K. C., Takasu O., Osborne D. F., Walton A. H., Bricker T. L., Jarman S. D. II, Kreisel D., Krupnick A. S., Srivastava A., Swanson P. E., Green J. M., Hotchkiss R. S., Immunosuppression in patients who die of sepsis and multiple organ failure. Journal of the American Medical Association 2011 306 23 2594 2605 2-s2.0-84255194001 10.1001/jama.2011.1829
6. Hotchkiss R. S., Coopersmith C. M., McDunn J. E., Ferguson T. A., The sepsis seesaw: tilting toward immunosuppression. Nature Medicine 2009 15 5 496 497 2-s2.0-66749164669 10.1038/nm0509-496
7. Bo L., Wang F., Zhu J., Li J., Deng X., Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Critical Care 2011 15 1, article R58 2-s2.0-79751531129 10.1186/cc10031
8. Jeschke M. G., The hepatic response to thermal injury: is the liver important for postburn outcomes? Molecular Medicine 2009 15 9-10 337 351 2-s2.0-70149104254 10.2119/molmed.2009.00005
9. Matuschak G. M., Henry K. A., Johanns C. A., Lechner A. J., Liver-lung interactions following Escherichia coli bacteremic sepsis and secondary hepatic ischemia/reperfusion injury. American Journal of Respiratory and Critical Care Medicine 2001 163 4 1002 1009 2-s2.0-0035060466 (Pubitemid 32275878)
10. Bauer M., Press A. T., Trauner M., The liver in sepsis: patterns of response and injury. Current Opinion in Critical Care 2013 19 2 123 127
11. Keir M. E., Butte M. J., Freeman G. J., Sharpe A. H., PD-1 and its ligands in tolerance and immunity. Annual Review of Immunology 2008 26 677 704 2-s2.0-42649125225 10.1146/annurev.immunol.26.021607.090331 (Pubitemid 351600389)
12. Saresella M., Rainone V., Al-Daghri N. M., Clerici M., Trabattoni D., The PD-1/PD-l1 pathway in human pathology. Current Molecular Medicine 2012 12 3 259 267 2-s2.0-84857128621 10.2174/156652412799218903
13. Zinselmeyer B. H., Heydari S., Sacristan C., Nayak D., Cammer M., Herz J., Cheng X., Davis S. J., Dustin M. L., McGavern D. B., PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. The Journal of Experimental Medicine 2013 210 4 757 774 10.1084/jem.20121416
14. Kulpa D. A., Lawani M., Cooper A., Peretz Y., Ahlers J., Sekaly R. P., PD-1 coinhibitory signals: the link between pathogenesis and protection. Seminars in Immunology 2013 10.1016/j.smim.2013.02.002
15. Yao S., Wang S., Zhu Y., Luo L., Zhu G., Flies S., Xu H., Ruff W., Broadwater M., Choi I.-H., Tamada K., Chen L., PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 2009 113 23 5811 5818 2-s2.0-67651099087 10.1182/blood-2009-02-203141
16. Zhang Y., Li J., Lou J., Zhou Y., Bo L., Zhu J., Zhu K., Wan X., Cai Z., Deng X., Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Critical Care 2011 15 1, article R70 2-s2.0-79951947339 10.1186/cc10059
17. Zhang Y., Zhou Y., Lou J., Li J., Bo L., Zhu K., Wan X., Deng X., Cai Z., PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Critical Care 2010 14 6, article R220 2-s2.0-78649460067 10.1186/cc9354
18. Inoue S., Bo L., Bian J., Unsinger J., Chang K., Hotchkiss R. S., Dose-dependent effect of anti-CTLA-4 on survival in sepsis. Shock 2011 36 1 38 44 2-s2.0-79959716811 10.1097/SHK.0b013e3182168cce
19. Koskinas J., Gomatos I. P., Tiniakos D. G., Memos N., Boutsikou M., Garatzioti A., Archimandritis A., Betrosian A., Liver histology in ICU patients dying from sepsis: a clinico-pathological study. World Journal of Gastroenterology 2008 14 9 1389 1393 2-s2.0-41149174772 10.3748/wjg.14.1389 (Pubitemid 351425219)
20. Li X. H., Gong X., Zhang L., Jiang R., Li H. Z., Wu M. J., Wan J. Y., Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1. Mediators of Inflammation 2013 2013 10 354087 10.1155/2013/354087
21. Zhu J., Wang J., Sheng Y., Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis. PloS One 2012 7 5 e35523
22. Wang B.-J., Bao J.-J., Wang J.-Z., Wang Y., Jiang M., Xing M.-Y., Zhang W.-G., Qi J.-Y., Roggendorf M., Lu M.-J., Yang D.-L., Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma. World Journal of Gastroenterology 2011 17 28 3322 3329 2-s2.0-80051961168 10.3748/wjg.v17.i28.3322
23. Mueller S. N., Vanguri V. K., Ha S.-J., West E. E., Keir M. E., Glickman J. N., Sharpe A. H., Ahmed R., PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice. Journal of Clinical Investigation 2010 120 7 2508 2515 2-s2.0-77954966127 10.1172/JCI40040